Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an Ideal Third Drug to ...

EAU CLAIRE, Wis. (EAU CLAIRE POLICE DEPARTMENT PRESS RELEASE) - The Eau Claire Police Department is pleased to release its ...

The corporation is required to pay interest on loans taken from the NBCFDC (National Backward Classes Finance and Development ...

On 21 March 2025, the Office of Financial Sanctions Implementation (OFSI) published its annual review for 2023-2024 period. The report highlights ...

Luxinnovation supported 891 companies in 2024, helping businesses innovate, adopt advanced digital technologies and enhance ...

The FDA has completed its review of the investigational new drug application (IND) for PSV359, and issued a "study may proceed” letter in 1Q 2025. Site activation activities are underway, with the ...

At ETBrandEquity’s CX Symposium 2025, PwC India’s Sanjay Dawar and Somick Goswami discussed how AI is reshaping customer ...

March 26, 2025, 7am CET BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious ...

The religious freedom watchdog urged the new Trump administration to appoint a new ambassador-at-large to address religious ...